HOME >> BIOLOGY >> NEWS
Columbia scientists determine 3-dimensional structure of cell's 'fuel gauge'

NEW YORK -- Researchers at Columbia University Medical Center have uncovered the complex structure of a protein that serves as a central energy gauge for cells, providing crucial details about the molecule necessary for developing useful new therapies for diabetes and possibly obesity. A paper published online today in the journal Science details this structure, helping to explain one of the cell's most basic and critical processes.

"Understanding this important protein's molecular structure and mechanism provides a major step forward for the rational design of new drugs to target diabetes and obesity," said Lawrence Shapiro, Ph.D., associate professor of Biochemistry and Jules and Doris Stein Professor of Research to Prevent Blindness at Columbia University Medical Center, and senior author of the paper.

The protein, known as AMP-activated protein kinase or AMPK, controls metabolic decisions of cells. For example, it controls the decision regarding whether fat is stored or burned, based on the amount of energy in the cell. When the energy level of a cell is high, meaning that the cell contains high amounts of an energy-carrying molecule known as ATP, AMPK directs cells toward "anabolic" activities like storing the extra energy as fat. When ATP is low, AMPK turns off anabolic activities, and activates "catabolic" functions, like burning fat to make energy.

AMPK provides an especially promising drug target for people with type 2 diabetes. These patients are insulin-resistant, meaning that their cells are not responsive to insulin which normally helps glucose get out of the bloodstream, where it does damage, and into cells. When AMPK detects low levels of ATP in the cell, it works through a different mechanism to increase how much glucose the cell takes in and uses to create ATP. Research in rodent models has shown that AMPK activators can lessen the pathologies associated with diabetes, including problems that diabetics have r
'"/>

Contact: Craig LeMoult
cel2113@columbia.edu
212-305-0820
Columbia University Medical Center
8-Feb-2007


Page: 1 2

Related biology news :

1. Columbia University Medical Center awarded $3 million to drive Alzheimers genetics research
2. Columbia University licenses next-generation DNA sequencing technology
3. New bird discovered on unexplored Columbian mountain
4. Columbia University Medical Center receives major new NIH Clinical Science investment funds
5. Columbia University awards 2006 Horwitz Prize to biologist who explained gene transcription
6. Columbia University receives $16.9 million NIEHS award to study arsenic in ground water
7. Contaminants linked to sturgeon decline in Columbia river
8. Columbia University Medical Center researchers discover potential mechanism for tumor growth
9. UF, Columbia scientists closer to new cancer detection method
10. Columbia University awards 2005 Horwitz Prize to Israeli structural biologist
11. Columbia wins major grant to examine genetic link to Alzheimers Disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2018)... RESTON, Va. (PRWEB) , ... August 14, 2018 ... ... stigmas were recently depicted in the movie “Wonder,” to a better understanding of ... defects treatments, according to editors of the latest special issue of Birth ...
(Date:8/7/2018)... EDWARDSVILLE, Ill. (PRWEB) , ... August 06, 2018 ... ... corn growing in front of The NCERC at Southern Illinois University Edwardsville’s University ... corn, but also grain sorghum and sweet sorghum. These three feedstocks represent conventional ...
(Date:8/2/2018)... ... August 02, 2018 , ... The ... innovator Boston Heart Diagnostics to its Lifestyle Medicine Corporate Roundtable, a group of ... care system and a sustainable world. , Boston Heart is transforming the ...
Breaking Biology News(10 mins):
(Date:7/25/2018)... MATEO, Calif. (PRWEB) , ... July 25, 2018 ... ... for in vivo research utilizing its state-of-the-art Digital Vivarium™ and Vium Cloud approach ... Schaevitz, Ph.D., to Chief Scientific Officer. Additionally, the company announced the appointment of ...
(Date:7/25/2018)... ... July 25, 2018 , ... John McDonald, CEO ... board of the Indiana India Business Council (IIBC), an advocacy group to strengthen ... current board of directors, McDonald joins an impressive roster of local and national ...
(Date:7/24/2018)... ... July 24, 2018 , ... Boval was founded in 1978 ... reagent suppliers. In Boval’s early days most of the BSA manufactured was for ... BSA for diagnostic purposes after gel cards changed that market and displaced most of ...
(Date:7/22/2018)... ... July 19, 2018 , ... Mitotech ... with Essex Bio-Investment for Phase 3 clinical program in Dry Eye Disease. Under ... SkQ1 with approximately $17m allocated towards the first Phase 3 study starting as ...
Breaking Biology Technology:
Cached News: